Celsius Holdings, Inc.

Celsius Holdings, Inc. (CELH) Stock Analysis

$32.980

-0.010 (-0.03%)At close

Loading chart…
High
33.270
Open
32.770
VWAP
32.79
Vol
6.02M
Mkt Cap
13.41B
Low
32.120
Amount
197.34M
EV/EBITDA, TTM
12.10

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.

AI analysis of Celsius Holdings, Inc. (CELH)

hold

Celsius Holdings Inc is currently a hold due to mixed signals in its performance and analyst outlook. The current price is $32.98, and while Goldman Sachs has a bullish target of $45, Deutsche Bank has downgraded it to Hold with a target of $35, reflecting concerns about the company's recent earnings miss and delayed recovery expectations. The RSI is at 54.103, indicating a neutral momentum, and the stock has seen a significant year-to-date decline of 30.93%. The main risk is the recent downgrade from Deutsche Bank, which suggests that the stock may not recover in the near term, while the potential upside remains limited until the company shows clearer signs of recovery.

Analyst Ratings (1)

+90.57% upside
Buy
1 Buy
0 Hold
0 Sell
Current: 32.98
Low
45.00
Average
62.85
High
80.00

Deutsche Bank

2026-08-27

Price Target

$35

Hold

Goldman Sachs

2026-08-10

Price Target

$45

Buy

Stephens

2026-08-10

Price Target

$50

Overweight

Morgan Stanley

2026-08-07

Price Target

$42

Overweight

Needham

2026-08-07

Price Target

$35

Buy

Valuation Metrics

The current forward P/E ratio for Celsius Holdings, Inc. (CELH) is 23.98, compared to its 5-year average forward P/E of 73.95.

Forward P/E

Fair
5Y Average P/E
73.95
Current P/E
23.98
Overvalued
143.65
Undervalued
4.25

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
43.94
Current EV/EBITDA
12.10
Overvalued
75.36
Undervalued
12.51

Forward P/S

Undervalued
5Y Average P/S
6.80
Current P/S
2.43
Overvalued
10.37
Undervalued
3.24

Alphio AI Price Scenarios for CELH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CELH

$36.73

Scenario price

B

Base

Base · 50%CELH

$34.22

Scenario price

B

Bear

Bear · 25%CELH

$28.13

Scenario price

Whales holding CELH

D

Divisadero Street Capital Management, LP

+ HoldingCELH

+7.83%

3M Return

V

Voss Capital, LP

+ HoldingCELH

+0.55%

3M Return

Events Timeline

2026-08-27 (ET)

16:30:00

Nvidia's Quarterly Report Drives Tech Stocks Higher

12:30:00

Nasdaq Rises 350.95 Points on Nvidia Earnings

2026-08-10 (ET)

16:30:00

Celsius Holdings Appoints New Executives to Drive Business Transformation

2026-08-07 (ET)

12:00:00

Celsius Shares Rise 12% to $26.61

News

CELH FAQ — answered by Alphio AI

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).

Celsius Holdings Inc is currently a hold due to mixed signals in its performance and analyst outlook. The current price is $32.98, and while Goldman Sachs has a bullish target of $45, Deutsche Bank has downgraded it to Hold with a target of $35, reflecting concerns about the company's recent earnings miss and delayed recovery expectations. The RSI is at 54.103, indicating a neutral momentum, and the stock has seen a significant year-to-date decline of 30.93%. The main risk is the recent downgrade from Deutsche Bank, which suggests that the stock may not recover in the near term, while the potential upside remains limited until the company shows clearer signs of recovery.

1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten